Feature

Odanacatib reduced fractures but upped stroke risk

Publish date: October 19, 2016

 

FROM THE NAMS 2016 ANNUAL MEETING

On Twitter @karioakes

Pages

Recommended Reading

Romosozumab boosts bone density while cutting resorption
MDedge Rheumatology
Yearly monitoring does not predict fractures after bisphosphonate cessation
MDedge Rheumatology
New agent builds bone bigger, faster
MDedge Rheumatology
Osteoporosis medication use down in older women
MDedge Rheumatology
Universal bisphosphonates after wrist fracture prevent hip fractures but at a cost
MDedge Rheumatology
Subclinical hyperthyroidism linked to higher fracture risk
MDedge Rheumatology
Osteoporosis trends collide for Mexican American women
MDedge Rheumatology
Denosumab better at building bone than zoledronic acid
MDedge Rheumatology
Early estrogen likely prevents bone fractures in Turner syndrome
MDedge Rheumatology
One-time AMH level predicts rapid perimenopausal bone loss
MDedge Rheumatology